The Global Acute Myeloid Leukemia Prognosis Market is forecast to reach USD 3.56 Billion by 2027, according to a new report by Reports and Data. The global Acute Myeloid Leukemia Prognosis market is expected to gain a lucrative increase over the forecast period due to the increasing occurrences of Acute Myeloid Leukemia Prognosis and its recurrence cases across the globe. Reinforcing...

Increasing diagnoses of AML are due to exposure to carcinogenics which are present everywhere. Changing lifestyles have given rise to unhealthy habits which lead to cancer. AML can also be passed genetically, and increased prevalences of cancer combined with the growing population drive the market. Other key factors of note which are affecting the market include improving reimbursement...